USE OF AN ERYTHROPOIETIN RECEPTOR ACTIVATOR IN PREGNANT WOMEN
The paper shows the high clinical and hematological efficiency of using a continuous erythropoietin receptor activator in combination with parenteral iron (III) dextran hydroxide versus monotherapy with the latter. The combined use was noted to be satisfactorily tolerated and to cause no side effects.